RecruitingNCT07356050

Verifying Antibodies After Live Immunization Delivery (VALID): A Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

Verifying Antibodies After Live Immunization Delivery (VALID): a Study of Measles Vaccine Immunogenicity in Children With Sickle Cell Disease

Sponsor

Children's Hospital Medical Center, Cincinnati

Enrollment

130 participants

Start Date

Mar 13, 2025

Study Type

OBSERVATIONAL

Conditions

Sickle Cell Disease Sickle Cell Anemia Measles Vaccination

Summary

The goal of this study is to learn if infants with sickle cell disease (SCD) develop adequate protection after measles vaccines. (not looking at any prolonged duration)

Eligibility

Min Age: 6 MonthsMax Age: 6 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with measles vaccination, sickle cell anemia, and other related conditions. The study is currently recruiting participants at 3 locations. People eligible for this study include aged 6 Months to 6 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.